Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plenum Osshp is a **synthetic biphasic bone substitute** composed of hydroxyapatite (HA, 70%) and β-tricalcium phosphate (β-TCP, 30%), engineered to be highly porous with ceramic particles optimized for osteoconductivity. It serves as a physical scaffold for bone regeneration, mimicking the structure of trabecular bone and facilitating homogeneous new bone formation. Its design allows for the adsorption of fluids and nutrients, and its synthetic nature ensures no risk of disease transmission from animal or human sources. Plenum Osshp is mainly used in dental surgery and implantology for guided bone regeneration in areas with critical bone defects, and has shown comparable efficacy to other commercial synthetic bone substitutes[1][3].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plenum Osshp synthetic biphasic bone scaffold (null).